Indian Pharma Market To Cross USD 130 Billions by 2030: Sadananda Gowda
The Indian pharmaceutical industry has proved to be a dependable supplier of quality drugs in a time of global need on account of the Covid-19 pandemic, and is expected to reach a size of USD 130 billion by 2030, Chemical and Fertiliser Minister D V Sadananda Gowda said.
Following the onset of the pandemic, the Indian pharma industry has shown its role as a reliable supplier of drugs and medical devices in a time of need, he added.
“The total market size of the Indian pharma industry is expected to reach USD 130 billion by 2030.
The medical devices industry in India has the potential to grow at 28 per cent per annum to reach USD 50 billion by 2025,” Gowda said.
He was addressing the curtain raiser press conference on the 6th edition of ‘Indian Pharma & India Medical Device 2021’. “India has been serving more than 200 countries with its pharma products and will continue to discharge its responsibilities.
